XBiotech Inc (XBIT)
8.11
-0.85
(-9.49%)
USD |
NASDAQ |
Apr 17, 16:00
8.10
-0.01
(-0.12%)
Pre-Market: 20:00
XBiotech Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 94.67% |
| September 30, 2022 | 87.20% |
| June 30, 2022 | 86.47% |
| March 31, 2022 | 57.40% |
| December 31, 2021 | 76.76% |
| September 30, 2021 | 75.44% |
| Date | Value |
|---|---|
| June 30, 2021 | 69.94% |
| March 31, 2021 | 52.49% |
| December 31, 2020 | 57.34% |
| September 30, 2020 | 10.65% |
| June 30, 2020 | 14.82% |
| March 31, 2020 | 23.71% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
10.65%
Minimum
Sep 2020
94.67%
Maximum
Dec 2022
58.91%
Average
63.67%
Median
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |